Clinical Trials Logo

Filter by:
NCT ID: NCT02695160 Terminated - Hemophilia B Clinical Trials

Ascending Dose Study of Genome Editing by Zinc Finger Nuclease Therapeutic SB-FIX in Subjects With Severe Hemophilia B

Start date: November 15, 2016
Phase: Phase 1
Study type: Interventional

The purpose of the study is to evaluate the safety, tolerability and effect on FIX antigen and activity levels of ascending doses of SB-FIX. SB-FIX is an intravenously delivered Zinc Finger Nuclease (ZFN) Therapeutic for genome editing. It inserts a correct copy of the Factor 9 gene into the albumin locus in hepatocytes with the goal of lifelong therapeutic production of the Factor IX clotting factor.

NCT ID: NCT02694757 Terminated - Ileostomy - Stoma Clinical Trials

Efficacy of Ostom-i Alert System at Decreasing Dehydration Related Complications

Start date: August 1, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the efficacy of the Ostom-i device in decreasing readmission rates of subjects with new ileostomies in the first 30 days post-operatively.

NCT ID: NCT02694666 Terminated - Falls Prevention Clinical Trials

Vibration Training for Preventing Falls in Healthy Population and Multiple Sclerosis

Start date: April 2016
Phase: N/A
Study type: Interventional

This study is to investigate the effects of controlled whole-body vibration training on reducing the likelihood of falls among healthy population and people with multiple sclerosis. (NOTE: research not covered by sponsored funding)

NCT ID: NCT02694380 Terminated - Breast Cancer Clinical Trials

Measuring the Effect of Radiation Therapy on Patient Activity Levels

Start date: July 2015
Phase:
Study type: Observational

The goal of this study is to measure the effect of radiation therapy on the activity levels of patients. This will be achieved by tracking their activity levels during a treatment course of radiation therapy.

NCT ID: NCT02693743 Terminated - Suicidal Ideation Clinical Trials

Repetitive Transcranial Magnetic Stimulation as Treatment for Acute Suicidality in Adult Patients

rTMS
Start date: May 22, 2017
Phase: N/A
Study type: Interventional

Suicide was responsible for almost 40,000 deaths in 2011 in America. It is still singularly difficult to predict who is going to commit suicide and how to establish adequate interventions. Growing evidence supports the view that suicide is associated with poor decision making. Suicide is hypothesized to be triggered by stressful situations that create overwhelming psychological pain in an individual who chooses to terminate his/her own life, disregarding all future consequences. We have previously demonstrated rewarding impulsive choice common to both recent suicide attempters and suicidal depressed patients (1). Consistent with these findings, we hypothesize that high frequency repetitive transcranial magnetic stimulation (rTMS) of the left prefrontal cortex will improve impulsive response tendencies as measured by the delay discounting procedure, and this in turn will be associated with a faster resolution of suicidal ideation. To these effects we will be using a randomized control trial of rTMS in adult inpatients at the Psychiatric Research Institute (PRI) hospitalized for acute suicidality. At the conclusion of these studies, we will have tested the value of decision making in the development of suicide ideation and behavior, as well as piloted the use of rTMS in the treatment of these patients.

NCT ID: NCT02693717 Terminated - Clinical trials for Metastatic Urothelial Carcinoma

Pemetrexed Disodium in Treating Patients With Previously Treated Metastatic Urothelial Cancer

Start date: May 9, 2017
Phase: Phase 2
Study type: Interventional

This phase II trial studies how well pemetrexed disodium works in treating patients with previously treated urothelial cancer that has spread from the primary site (place where it started) to other places in the body. Pemetrexed disodium may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

NCT ID: NCT02693353 Terminated - Macular Edema Clinical Trials

Epiretinal Membrane and Pseudophakic Cystoid Macular Edema

Start date: February 2016
Phase:
Study type: Observational

Prospective, observational cohort study evaluating the association between pre-surgical existence of an epiretinal membrane (ERM) and the development of pseudophakic cystoid macular edema (PCME) using spectral domain optical coherence tomography (OCT) measurements.

NCT ID: NCT02693171 Terminated - Neuroblastoma Clinical Trials

Post-Marketing Assessment of Immunogenicity and Safety of Unituxin® in High-Risk Neuroblastoma Patients

Start date: March 15, 2016
Phase:
Study type: Observational

The purpose of this study was to assess the incidence of human anti-chimeric antibody (HACA) in high-risk neuroblastoma patients treated with Unituxin combination therapy.

NCT ID: NCT02693002 Terminated - Menopause Clinical Trials

Estrogen Diastolic Heart Failure

Start date: February 2016
Phase: Phase 4
Study type: Interventional

Peri-menopausal women will be randomized to hormone replacement therapy or placebo for 12 weeks to determine if markers of systolic and diastolic function change by echocardiography as well as laboratory markers of heart failure, including b-type natriuretic peptide (BNP).

NCT ID: NCT02692898 Terminated - Brain Cancer Clinical Trials

Biomarker Analysis of Central Nervous System Tumors

Start date: February 25, 2016
Phase:
Study type: Observational

Background: The number of people who get tumors of the brain or central nervous system (CNS) is lower than other cancers. But these tumors cause a higher rate of serious effects and even death. Researchers want to test existing samples of tissue from these tumors to learn more about them. This may lead to better treatment. Objective: To study stored samples of CNS tumors to learn more about the tumors and explore new ways to diagnose them. Eligibility: The study will use tissue samples already collected at NIH from people with brain or CNS tumors. Design: The participants will have given their consent in a previous study. Researchers will review the tissue samples and any data collected about them. Researchers will do lab tests and scans on the samples. All data will be kept secure.